CELL INTELLIGENCE · 肿瘤细胞治疗研究

AML/MDS 细胞治疗的最新进展

Recent advances in cell therapy for AML/MDS.

异基因移植后急性髓系白血病复发中重编程失败的移植物抗白血病免疫的研究进展

Progress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation.

CAR-T 细胞治疗的机制、优化策略和挽救方案

Mechanisms, optimization strategies, and salvage options for CAR-T cell therapy.

单细胞 RNA 测序揭示急性髓系白血病肿瘤微环境的免疫异质性

Single-cell RNA sequencing reveals immunological heterogeneity of the tumor microenvironment in acute myeloid leukemia.

本研究强调了 AML 微环境中的细胞异质性及复杂的免疫相互作用，为理解免疫逃逸提供了见解，并为未来的免疫治疗及靶向治疗策略提供了依据。

CAR-T 与 CAR NK 细胞治疗急性髓系白血病的最新进展

Recent advances in CAR T and CAR NK cell therapy for AML.

工程化精准肿瘤学：以慢病毒载体靶向肿瘤与免疫细胞

Engineering precision oncology: Targeting tumors and immune cells with lentiviral vectors.

神经母细胞瘤的肿瘤微环境与免疫治疗策略：迈向更有效的治疗

Tumor Microenvironment in Neuroblastoma and Immunotherapeutic Approaches: Towards More Effective Treatment.

供者来源 CD19 靶向 CAR-NK 细胞在 blinatumomab 和自体 CD19 靶向 CAR-T 治疗失败后诱导复发 B-ALL 患儿完全缓解

Donor-derived CD19-targeted CAR-NK cells induce complete remission in a child with relapsed B-ALL after failure of blinatumomab and autologous CD19-ta

CAR-CIK 细胞在异基因干细胞移植后复发急性白血病中的治疗潜力

Therapeutic Potential of CAR-CIK Cells in Acute Leukemia Relapsed Post Allogeneic Stem Cell Transplantation.

CAR-T 细胞与其他免疫疗法整合以提高癌症患者疗效

Integrating CAR-T cells with other immunotherapies for improved efficacy in cancer patients.